Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-11-27 4:10 pm Purchase | 13G | Compass Therapeutics, Inc. CMPX | ADAGE CAPITAL PARTNERS GP L.L.C. | 7,211,800 5.66% | 7,211,800 (New Position) | View |
| 2023-11-20 4:30 pm Purchase | 13G | Aeva Technologies, Inc. AEVA | ADAGE CAPITAL PARTNERS GP L.L.C. | 16,225,227 6.23% | 16,225,227 (New Position) | View |
| 2023-11-03 4:56 pm Purchase | 13G | Nkarta, Inc. NKTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,700,000 7.54% | 3,700,000 (New Position) | View |
| 2023-10-12 4:30 pm Purchase | 13G | Soleno Therapeutics, Inc. SLNO | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,327,000 8.69% | 1,327,000 (New Position) | View |
| 2023-10-10 4:52 pm Purchase | 13G | Sutro Biopharma, Inc. STRO | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,549,320 5.86% | 3,549,320 (New Position) | View |
| 2023-09-11 4:45 pm Purchase | 13G | CymaBay Therapeutics, Inc. CBAY | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,685,625 3.76% | 1,525,475 (+70.62%) | View |
| 2023-08-31 5:28 pm Purchase | 13G | Verastem, Inc. VSTM | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,300,000 5.15% | 1,300,000 (New Position) | View |
| 2023-08-25 4:30 pm Purchase | 13G | Benitec Biopharma Inc. BNTC | ADAGE CAPITAL PARTNERS GP L.L.C. | 189,188 7.5% | 189,188 (New Position) | View |
| 2023-07-19 4:30 pm Sale | 13G | Grosvenor Capital Management, L.P. GCMG | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,595,986 6.2% | -2,346,800 (-47.48%) | View |
| 2023-07-18 3:05 pm Purchase | 13G | Molecular Templates, Inc. MTEM | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,391,489 5.45% | 4,391,489 (New Position) | View |
| 2023-07-06 4:31 pm Purchase | 13G | Abeona Therapeutics Inc. ABEO | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,249,994 15.32% | 1,918,834 (+144.15%) | View |
| 2023-07-06 4:20 pm Purchase | 13G | Marinus Pharmaceuticals, Inc. MRNS | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,756,250 5.45% | 1,293,750 (+88.46%) | View |
| 2023-06-30 4:52 pm Purchase | 13G | Praxis Precision Medicines, Inc. PRAX | ADAGE CAPITAL PARTNERS GP L.L.C. | 7,930,638 6.17% | 7,930,638 (New Position) | View |
| 2023-06-30 4:30 pm Purchase | 13G | Disc Medicine, Inc. IRON | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,162,624 5.24% | 812,562 (+232.12%) | View |
| 2023-06-26 4:46 pm Purchase | 13G | Reata Pharmaceuticals, Inc. RETA | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,730,841 5.24% | 1,730,841 (New Position) | View |
| 2023-06-12 4:30 pm Purchase | 13G | TScan Therapeutics, Inc. TCRX | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,000,000 9.35% | 4,000,000 (New Position) | View |
| 2023-04-13 4:30 pm Purchase | 13G | Protagonist Therapeutics, Inc. PTGX | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,955,000 5.44% | 1,804,955 (+156.95%) | View |
| 2023-04-10 4:59 pm Purchase | 13G | Akero Therapeutics, Inc. AKRO | ADAGE CAPITAL PARTNERS GP L.L.C. | 2,802,627 5.97% | 2,802,627 (New Position) | View |
| 2023-03-13 4:30 pm Purchase | 13G | Travere Therapeutics, Inc. TVTX | ADAGE CAPITAL PARTNERS GP L.L.C. | 4,418,962 5.94% | 1,818,962 (+69.96%) | View |
| 2023-03-06 4:40 pm Purchase | 13G | Fulcrum Therapeutics, Inc. FULC | ADAGE CAPITAL PARTNERS GP L.L.C. | 3,470,547 5.63% | 2,350,547 (+209.87%) | View |